General Meeting Result

Summary by AI ^BETAClose X

Develop North PLC announced that all resolutions presented at its General Meeting on February 18, 2026, were passed unanimously, with 15,799,780 votes for each resolution and zero votes against or withheld. This includes the adoption of the Proposed Investment Objective and Investment Policy, and grants directors authority to allot up to 368 million Ordinary Shares and/or C Shares for the Initial Issue and Share Issuance Programme, along with the disapplication of pre-emption rights for these issuances. The company also secured authorities for market purchases of shares following initial and subsequent admissions.

Disclaimer*

Develop North PLC

18 February 2026

DEVELOP NORTH PLC

(the "Company" or "DVNO" or "Develop North")

Result of General Meeting

18 February 2026

The Company is pleased to announce that all resolutions put to the General Meeting of the Company held earlier today were duly passed on a poll. Accordingly, the Proposed Investment Objective and Investment Policy has been adopted and the Directors have been granted the authorities set out in the Circular, including the authority to allot and issue up to 368 million Ordinary Shares and/or C Shares in connection with the Initial Issue and the Share Issuance Programme. Defined terms used in this announcement have the meanings given in the Company's circular to Shareholders published on 16 January 2026 (the "Circular").

Details of the number of votes cast for, against and withheld in respect of each resolution are set out below and will also be published on the Company's website at www.developnorth.co.uk.

Resolution	Votes For	%	Votes Against	%	Votes Total	Votes Withheld
1. Authority to allot Ordinary Shares and/or C Shares in connection with the Initial Issue and the Share Issuance Programme	15,799,780	100%	0	0.00%	15,799,780	0
2. Disapplication of pre-emption rights in connection with the Initial Issue and the Share Issuance Programme	15,799,780	100%	0	0.00%	15,799,780	0
3. Adoption of the Proposed Investment Objective and Investment Policy	15,799,780	100%	0	0.00%	15,799,780	0
4. Additional authority to allot Ordinary Shares	15,799,780	100%	0	0.00%	15,799,780	0
5. Additional disapplication of pre-emption rights	15,799,780	100%	0	0.00%	15,799,780	0
6. Authority to make market purchases of Ordinary Shares following Initial Admission	15,799,780	100%	0	0.00%	15,799,780	0
7. Authority to make market purchases of Ordinary Shares and/or C Shares following any Subsequent Admission	15,799,780	100%	0	0.00%	15,799,780	0
8. Adoption of the New Articles	15,799,780	100%	0	0.00%	15,799,780	0

Notes:

1. A "vote withheld" is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against each resolution.

The full text of the resolutions is set out in the Notice of General Meeting contained in the Circular.

A copy of the resolutions passed at the General Meeting has been submitted to the National Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information regarding the Company (Ticker: DVNO) (LEI: 213800EXPWANYN3NEV68) please call:


Develop North PLC Ian McElroy	+44 (0) 191 222 0099
Tier One Capital Limited (Investment Adviser) Brendan O'Grady	+44 (0) 191 222 0099
Cavendish Capital Markets Limited (Financial Adviser and Corporate Broker) Robert Peel Andrew Worne Oscar Valeur-Adu	+44 (0) 207 220 0500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END